Illumina Expands Genomics in India with New Solutions Center

Illumina's expansion comes after 16 years of working closely with the company's channel partner in India, Premas Life Sciences. Now with its own permanent ...

August 21, 2023 | Monday | News
FDA Prioritizes TARPEYO Full Approval for IgA Nephropathy Treatment

TARPEYO is currently approved under accelerated approval to reduce proteinuria in adults with primary IgA nephropathy (IgAN) at risk of rapid disease progr...

August 21, 2023 | Monday | News
3Z and biotx.ai Partner to Enhance ADHD Drug Development with AI Modeling

3Z, holds expertise in developing genetically engineered models of central nervous system disorders, has successfully identified potential ADHD treatments ...

August 21, 2023 | Monday | News
AstraZeneca Sets Sights on Treating 50%+ Lung Cancer Patients by 2030 with WCLC Data

FLAURA2 data reinforce TAGRISSO® as backbone therapy for EGFR-mutated advanced lung cancer in combination with chemotherapy; granted Breakthrough Thera...

August 17, 2023 | Thursday | News
TAE Life Sciences Partners with Biddle Sawyer for Cancer Treatment Drug

TAE Life Sciences has  announced a landmark agreement with Biddle Sawyer to serve as the exclusive supplier of TC220, a novel boronated amino aci...

August 16, 2023 | Wednesday | News
Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Part...

August 15, 2023 | Tuesday | News
Zetagen Raises $9.79M Series B for ZetaMet™ and ZetaMAST™ in Metastatic Lesion Treatment

ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently i...

August 14, 2023 | Monday | News
Novartis Completes Acquisition of Chinook Therapeutics

Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront Deal brings two phase 3 assets in d...

August 14, 2023 | Monday | News
Genprex's REQORSA® Granted FDA Orphan Drug Designation for Small Cell Lung Cancer

ODD is in addition to Three FDA Fast Track Designations Genprex expects to dose the first patient in the­­­­ Acclaim-3...

August 11, 2023 | Friday | News
Thermo Fisher to Coordinate Transplant Stats for US NIH

T-SCCC will support initiatives seeking to ensure success of organ transplants for patients The PPD clinical research business of Thermo Fisher Scientific...

August 11, 2023 | Friday | News
PAN-TB Begins Phase 2 Trial for New TB Treatments

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the start of a phase 2b/c clinical trial, sponsored by the...

August 10, 2023 | Thursday | News
FDA Approves First Oral Treatment for Postpartum Depression

"Postpartum depression is a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness—even, in sever...

August 07, 2023 | Monday | News
Bavarian Nordic's Chikungunya Vaccine Shows Positive Phase 3 Results in Adults and Adolescents

Chikungunya vaccine candidate met all the co-primary endpoints of the Phase 3 study and was shown to be highly immunogenic in the majority of subjects 22...

August 07, 2023 | Monday | News
LianBio Begins Phase 1 Trial for SHP2 Inhibitor BBP-398 Combo with Osimertinib in EGFR-Mutated Lung Cancer

SHP2 is a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signaling with the downstream RAS/MAPK pathway to regulate cellular ...

August 04, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close